Condition: Lung Cancer · Pulmonary Nodule, Solitary · Sponsor: Abramson Cancer Center at Penn Medicine
This is a pragmatic clinical trial that will study the effect of a radiomics-based computer-aided diagnosis (CAD) tool on clinicians' management of pulmonary nodules (PNs) compared to usual care. Adults aged 35-89 years with 8-30mm PNs evaluated at Penn Medicine PN clinics will undergo 1:1 randomization to one of two groups, defined by the PN malignancy risk stratification strategy used by evaluating clinicians: 1) usual care or 2) usual care + use of a radiomics-based CAD tool.
This description comes directly from the study's public registry record.
Roger Y. Kim, MD, MSCE · 215-662-3677 · roger.kim@pennmedicine.upenn.edu
Anil Vachani, MD, MSCE · 215-573-7931 · avachani@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| Penn Medicine University City | Philadelphia, Pennsylvania, United States | Recruiting |
| Perelman Center for Advanced Medicine | Philadelphia, Pennsylvania, United States | Recruiting |
| Penn Medicine Washington Square | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05968898